Abstract
Background:
CollaboRATE is a 3-item instrument that measures patients’ perceived shared decision-making. Compared to other shared decision-making measures, it demonstrates strong content validity and is brief enough for use in busy clinical environments. However, no Korean version is currently available.
Objectives:
This study aimed to translate CollaboRATE into Korean and evaluate its psychometric properties among multimorbid patients with hypertension.
Methods:
The original version of CollaboRATE was translated into Korean using a forward- and back-translation process. Cognitive interviews were conducted with 6 patients. A cross-sectional survey was then conducted with 503 patients to evaluate the psychometric properties. Internal consistency was assessed using Cronbach’s alpha, and structural validity was examined with exploratory and confirmatory factor analyses. Construct validity was evaluated with hypothesis testing.
Results:
Based on the cognitive interviews, several phrases were revised to improve item clarity. Cronbach’s alpha for the Korean version of CollaboRATE was 0.93. Factor analysis suggested a one-factor structure. As hypothesized, CollaboRATE scores were positively correlated with scores of the Shared Decision Making Q-9 (r = 0.67), the Patient Activation Measure (r = 0.17), and the Partners in Health Scale measuring self-care (r = 0.36), supporting its construct validity.
Conclusion:
The Korean version of CollaboRATE is a reliable and valid instrument for assessing patients’ perceptions of shared decision-making.
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
